Park West Asset Management LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
Park West Asset Management LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$7,134,000
-3.7%
2,468,5870.0%0.40%
+56.8%
Q1 2022$7,406,000
-0.5%
2,468,587
+52.5%
0.26%
+74.8%
Q4 2021$7,446,000
-28.9%
1,618,587
-3.0%
0.15%
-41.0%
Q3 2021$10,479,000
+4.8%
1,668,5870.0%0.25%
-12.6%
Q2 2021$9,995,000
-1.1%
1,668,587
+4.4%
0.28%
-6.9%
Q1 2021$10,107,000
+20.4%
1,597,987
+7.2%
0.31%
+75.9%
Q4 2020$8,395,000
-1.0%
1,491,065
+2.3%
0.17%
-47.0%
Q3 2020$8,483,000
-19.3%
1,457,5070.0%0.33%
-37.0%
Q2 2020$10,509,000
+40.6%
1,457,507
-8.8%
0.52%
+2.8%
Q1 2020$7,476,000
-39.7%
1,597,507
+3.4%
0.51%
-2.9%
Q4 2019$12,391,000
+3.1%
1,545,075
-11.6%
0.52%
-10.9%
Q3 2019$12,023,000
-17.1%
1,747,5070.0%0.59%
-2.7%
Q2 2019$14,504,000
-7.2%
1,747,507
+11.1%
0.60%
-12.2%
Q1 2019$15,631,000
+22.2%
1,572,507
-6.0%
0.69%
+8.5%
Q4 2018$12,794,000
-42.1%
1,672,507
+31.8%
0.63%
-21.5%
Q3 2018$22,108,000
+462.5%
1,269,107
+206.5%
0.80%
+451.4%
Q2 2018$3,930,000
+79.9%
414,107
-17.2%
0.15%
+50.5%
Q1 2018$2,185,000
-10.3%
500,000
-16.7%
0.10%
-12.6%
Q4 2017$2,436,000
+537.7%
600,000
+200.0%
0.11%
+382.6%
Q3 2017$382,000
+76.9%
200,0000.0%0.02%
+91.7%
Q2 2017$216,000200,0000.01%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders